USTR sets 100% tariff on Chinese syringes; Retractable files suit; declares preferred dividend

RETRACTABLE TECHNOLOGIES INC

USTR finalized 100% tariff on Chinese syringes/needles effective Sept 27, 2024; Retractable sourced 91% from China in H1 2024.
Retractable filed complaint in U.S. Court of International Trade on Sept 26 to challenge tariff; seeks injunction and to set aside tariff.
H1 2024 net revenues $13.6M, operating loss $8.7M; warns tariff may force layoffs and threaten prior government investment.
Board declared Q3 preferred dividends of $39,050 (Series II) and $18,561 (Series III), payable Oct 21 to holders of record Oct 10.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.